SEMAX Research Profile

Current catalog abstract

Documented material overview

Semax: ACTH-Derived Neurological Research Peptide Semax is a synthetic seven-amino-acid peptide derived from a short fragment of adrenocorticotropic hormone (ACTH). Its amino-acid sequence is Met-Glu-His-Phe-Pro-Gly-Pro. Unlike full-length ACTH, Semax is studied primarily for neurological activity rather than hormonal effects. It has attracted scientific interest because of its observed influence on neurotrophic signaling, gene expression, learning, memory, and cellular responses to neurological stress in experimental models. Researchers study Semax for its potential role in: • Brain-derived neurotrophic factor (BDNF) signaling • TrkB receptor activity • Nerve growth factor (NGF) expression • Learning, memory, and cognitive pathways • Neuroplasticity and neuronal survival • Oxidative-stress and inflammation models • Cerebral-ischemia research • Immune- and vascular-related gene expression Preclinical studies suggest that Semax may influence the BDNF/TrkB signaling system, which plays an important role in neuronal survival, synaptic plasticity, learning, and memory. Laboratory and animal studies have also examined changes in immune, vascular, and neurotrophic gene expression following exposure to Semax. These findings make Semax an important research tool for investigating how peptide signaling may affect the nervous system under normal and experimentally induced stress conditions. However, the available evidence does not establish Semax as a treatment for stroke, memory loss, cognitive impairment, or any other medical condition in humans. Important Notice Semax is intended strictly for laboratory research and analytical use. It is not approved by the FDA for human consumption, medical treatment, cognitive enhancement, veterinary use, or diagnostic purposes. Laboratory and animal findings should not be interpreted as established benefits in humans.